in the absence of a submission from the holder of the marketing authorisation
fenticonazole (Ginoxin®) is not recommended for use within NHS Scotland.
Indication under review: treatment of vulvovaginal candidiasis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice69KB (PDF)
- Medicine name:
- fenticonazole (Ginoxin)
- SMC ID:
- treatment of vulvovaginal candidiasis.
- Pharmaceutical company
- Recordati Pharmaceuticals
- Submission type
- Non submission
- Not recommended
- Date advice published
- 07 February 2011